Drug intelligence / Profile preview

GASOKEY-A

Development stage: Unknown
Lead developer: JoY Pharma
Modality: Small Molecules
Administration: Oral

Overview

GASOKEY-A is a branded generic combination medication marketed by JoY Pharma, a pharmaceutical company based in Bengaluru, India. It is formulated as an oral suspension indicated for the treatment of gastrointestinal disorders associated with hyperacidity and gas, such as gastritis, peptic ulcers, heartburn, and flatulence. The medication contains two primary active ingredients: magaldrate and simethicone. Magaldrate is a complex aluminosilicate antacid that works by neutralizing excess gastric hydrochloric acid, thereby increasing the pH of the stomach. Simethicone is an anti-foaming agent that reduces the surface tension of gas bubbles in the digestive tract, allowing them to coalesce and be more easily expelled, which provides relief from bloating and abdominal discomfort.

Brand names: GASOKEY-A

Beyond the preview

Go deeper on GASOKEY-A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GASOKEY-A.

Explore the full profile